INTELLIGENT RETINAL IMAGING SYSTEMS
About INTELLIGENT RETINAL IMAGING SYSTEMS
Intelligent Retinal Imaging Systems (IRIS) is a pioneering healthcare AI company dedicated to combating preventable blindness through advanced retinal screening technology. The company’s core offering is a cloud-based platform that leverages artificial intelligence for the autonomous detection of diabetic retinopathy and other ocular diseases. This camera-agnostic system seamlessly integrates with existing Electronic Medical Record (EMR) systems, enabling primary care physicians, Federally Qualified Health Centers, and health systems to conduct efficient and scalable retinal screenings as part of routine preventive care.
The IRIS platform plays a crucial role in enhancing bidirectional care coordination between primary care providers and eye care specialists. By facilitating early identification of patients at risk for ocular disease during primary care visits, it allows for timely referrals to ophthalmologists and optometrists. Conversely, eye care professionals can utilize AI-analyzed ocular data to detect signs of systemic or neurological diseases, enabling appropriate referrals back to primary care for further evaluation. Since its founding, IRIS has facilitated over 1.8 million screenings, leading to the identification of more than 279,000 cases of diabetic retinopathy. Furthermore, IRIS is actively developing diagnostic modules to extend the clinical value of ocular data for the detection of cardiovascular disease, chronic kidney disease, and early Alzheimer’s disease. The company was acquired by Topcon Healthcare, integrating its technology into Topcon’s “Healthcare from the Eye” initiative to further empower AI-driven clinical decision-making.
Focus Areas
Business Intelligence
| Key Investors | Ballast Point Ventures, Providence Ventures, CoxHealth, Allumia Ventures |
| Partnerships | AEYE Health (July 2023), Thirona Retina BV (August 2023), Microsoft AI for Health Initiative (2020), Biomedix (February 2021), Prisma Health |
| Acquisitions | Acquired by Topcon Healthcare (July 2025) |
| Technology | Cloud-based, camera-agnostic platform, proprietary image capture and enhancement technology, AI-assisted diagnostics, EMR/EHR integration, remote reading center with board-certified ophthalmologists and retina specialists |
| FDA Clearances | 1 (for its core platform) cleared products (estimated) |
What Physicians Need to Know
For physicians, IRIS stands out by simplifying preventative eye care, especially for diabetic patients, directly within the primary care setting. Its camera-agnostic and cloud-based nature means easy integration with existing equipment and workflows, reducing the need for patient referrals to specialists for initial screenings. The combination of AI-assisted image enhancement and rapid, expert human interpretation from the IRIS Reading Center provides accurate and timely diagnoses, improving patient outcomes through early detection. This not only helps close care gaps and meet quality metrics (like HEDIS and Star ratings) but also reduces administrative burden and can drive additional revenue for practices by enabling more comprehensive in-house services. The ability to screen for multiple conditions like diabetic retinopathy, macular edema, and suspected glaucoma with a single platform offers a holistic approach to eye health management.
IRIS offers robust and seamless integration capabilities. The platform is entirely cloud-based, ensuring accessibility and scalability. It is camera-agnostic, meaning it can integrate with a wide variety of existing fundus cameras (both stationary and handheld), eliminating the need for new hardware investments. For EMR/EHR integration, IRIS supports both on-premise and cloud-based systems, utilizing the IRIS EMR Proxy application and HL7 messaging for secure and efficient bidirectional data transfer, ensuring patient records are updated with images and diagnoses automatically. This 'plug-and-play' approach minimizes disruption to existing clinical workflows.
What the Web Says
Intelligent Retinal Imaging Systems (IRIS) generally receives positive feedback for its product, particularly for its ease of use, integration capabilities, and effectiveness in detecting diabetic retinopathy. However, employer reviews indicate some dissatisfaction with management, work-life balance, and compensation, leading to a mixed overall sentiment for the company as an employer.
Overall: MixedStrengths
- Easy to use and intuitive product interface for clinicians.
- Effective in early detection of diabetic retinopathy.
- Good integration with existing EHR systems.
- Responsive customer support for product issues.
- Positive impact on patient care and outcomes.
- Streamlines workflow for retinal screenings.
Limitations
- Management issues and lack of clear direction (employer reviews).
- Poor work-life balance and long hours (employer reviews).
- Compensation perceived as low by some employees (employer reviews).
- Limited opportunities for career advancement (employer reviews).
- Some reports of high employee turnover (employer reviews).
- Initial setup and training can be time-consuming for new users.
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News/Review Sites
Last updated: 2026-07-20
Videos
News, demos, and interviews about INTELLIGENT RETINAL IMAGING SYSTEMS.
Videos load interactively. If none appear, search YouTube for INTELLIGENT RETINAL IMAGING SYSTEMS →
Press & Coverage
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]